Compare LADR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LADR | CERT |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2013 | 2020 |
| Metric | LADR | CERT |
|---|---|---|
| Price | $8.48 | $11.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $11.61 | ★ $12.68 |
| AVG Volume (30 Days) | 2.2M | ★ 2.6M |
| Earning Date | 10-16-2026 | 11-05-2026 |
| Dividend Yield | ★ 10.80% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $40.40 | N/A |
| Revenue Next Year | N/A | $3.64 |
| P/E Ratio | $12.93 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $8.48 | $4.45 |
| 52 Week High | $11.48 | $12.61 |
| Indicator | LADR | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 33.12 | 65.90 |
| Support Level | N/A | $6.26 |
| Resistance Level | $10.45 | $12.61 |
| Average True Range (ATR) | 0.22 | 0.65 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 4.82 | 68.74 |
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.